Apellis Pharmaceuticals, Inc. (APLS)
NASDAQ: APLS · Real-Time Price · USD
19.94
-0.13 (-0.65%)
Mar 9, 2026, 3:18 PM EDT - Market open
Apellis Pharmaceuticals Market Cap
Apellis Pharmaceuticals has a market cap or net worth of $2.55 billion as of March 9, 2026. Its market cap has decreased by -27.72% in one year.
Market Cap
2.55B
Enterprise Value
2.52B
1-Year Change
-27.72%
Ranking
Category
Stock Price
$19.94
Market Cap Chart
Since November 9, 2017, Apellis Pharmaceuticals's market cap has increased from $691.10M to $2.55B, an increase of 268.82%. That is a compound annual growth rate of 16.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.57B | -19.28% |
| Dec 31, 2025 | 3.18B | -19.93% |
| Dec 31, 2024 | 3.97B | -44.04% |
| Dec 29, 2023 | 7.09B | 24.06% |
| Dec 30, 2022 | 5.72B | 38.54% |
| Dec 31, 2021 | 4.13B | -4.73% |
| Dec 31, 2020 | 4.33B | 121.45% |
| Dec 31, 2019 | 1.96B | 163.72% |
| Dec 31, 2018 | 741.80M | -32.09% |
| Dec 29, 2017 | 1.09B | 58.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 2.82B |
| Vera Therapeutics | 2.79B |
| Arcus Biosciences | 2.77B |
| Beam Therapeutics | 2.64B |
| Telix Pharmaceuticals | 2.56B |
| Travere Therapeutics | 2.51B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |